High Percentage Of Heart Patients Receive Off-Label And Untested Drug-Coated Stents

Armen Hareyan's picture

One-year follow-up showed patients receiving stents off-label or untested faired similarly to patients who fit FDA criteria for standard use.

A one-year study of roughly 5,500 patients who underwent angioplasty for the insertion of drug-eluting stents (DES) found that nearly half of those patients

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.